DURHAM, N.C. & SEATTLE--January 12, 2025--Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and...
Art Pappas to participate on panel, "Investing in Neurotech" at Neurotech Investing and Partnering Conference in Boston, MA
News | 05. 19. 2010
